BioNTech SE
BNTX
$105.07
-$5.81-5.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -381.92M | -812.62M | -717.13M | -500.78M | -543.77M |
| Total Depreciation and Amortization | 328.05M | 323.87M | 320.41M | 228.93M | 225.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -488.45M | -405.26M | -700.03M | -349.75M | -155.93M |
| Change in Net Operating Assets | -1.31B | 627.61M | 1.31B | 2.24B | 3.68B |
| Cash from Operations | -1.85B | -266.41M | 210.70M | 1.62B | 3.21B |
| Capital Expenditure | -233.24M | -297.85M | -309.90M | -329.01M | -307.75M |
| Sale of Property, Plant, and Equipment | 2.17M | 1.82M | 1.29M | 545.10K | 215.30K |
| Cash Acquisitions | -82.61M | -82.61M | -- | 0.00 | -366.69M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.04B | 1.92B | -1.96B | -5.49B | -6.33B |
| Cash from Investing | 1.73B | 1.54B | -2.27B | -5.82B | -7.00B |
| Total Debt Issued | -- | -- | -- | 200.00K | 300.00K |
| Total Debt Repaid | -42.30M | -51.90M | -45.90M | -50.90M | -52.40M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -800.00K | -302.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.08M | -55.64M | -49.58M | -55.69M | -385.50M |
| Foreign Exchange rate Adjustments | 5.47M | -8.53M | 15.80M | -149.20M | -80.06M |
| Miscellaneous Cash Flow Adjustments | 23.37M | 59.47M | 3.45M | 194.09M | 151.10M |
| Net Change in Cash | -139.33M | 1.27B | -2.09B | -4.21B | -4.11B |